Emerging Strategies in Cancer Metabolism

Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has extensive teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for cancer and neurodegenerative disorders. His research interests focus on advanced pharmaceutical formulations and controlled delivery approaches aimed at improving therapeutic outcomes.Dr. Mishra has supervised postgraduate and doctoral research scholars and has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He is also associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, research, and pharmaceutical education. He has additionally been recognized internationally for his research impact and scholarly contributions in the field of pharmaceutical sciences.Dr. Kuttiappan Anitha is working as Assistant Professor in School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience. Dr. Anitha is recipient of “Excellence in Academic Award” 2022 from International School of Technology and Sciences Affiliated from Govt. of India. She has guided more than 45 M.Pharm students and more than 10 batches of UG Projects. She has more than 30 publications in both national and international journals. Her area of expertise includes Immunooncology, endocrine areas, Gut Microbiota, infectious Diseases. She has also written several books and many book chapters. She has organized Conferences/seminars at university levels.Goutam Rath is a professor in the Department of Pharmaceutics at the School of Pharmaceutical Sciences, Siksha 'O' Anusandhan, Bhubaneswan, India. A leading researcher in nanotechnology-based platforms for targeted drug and bioactive delivery, he has earned international recognition for his scientific contributions. He has consistently ranked among the world’s top 2% scientists, as listed by Stanford University, for multiple years. In 2018, he was named among India’s top scientists by Career 360 and recognized by the USFDA for excellence in GMP practices. His work continues to advance pharmaceutical innovation and global health impact. Prof. Rath has successfully led numerous national research projects with cumulative funding exceeding ₹22.2 crores from prestigious agencies like NITI Aayog, DBT, DST, AICTE, UGC, and ICMR. He has authored over 250 peer-reviewed publications with a cumulative impact factor of approximately 1080, an h-index of 59, and over 10,800 citations. Additionally, he has contributed to four textbooks, 20 book chapters, and over 60 scientific presentations. His innovative work is protected by 21 patents, six of which have been commercially transferred, generating revenues of ₹37 lakhs. He currently supervises 85 M.Pharm and 10 Ph.D. scholars, and serves on multiple national expert panels in biotechnology and nanomedicine.

• 1. Introduction to Gut Microbiota in Cancer Metabolism2. Cancer Metabolic Rewiring of Reactive Oxygen Species3. Emerging strategies in Cancer metabolism: Role of Gut microbiota, reactive oxygen species, and short chain fatty acids4. Exploring the Link Between Gut Microbiome and Cancer: Metabolic Implications and Therapeutic Avenue5. Oxidative Stress and Cancer Metabolism: From Pathogenesis to Therapeutic Opportunities6. Targeting ROS Signaling Pathways for Cancer Metabolic Reprogramming7. SCF Complex: Master Regulator of Metabolic Adaptations in Cancer Cells8. Manipulating gut microbial metabolites for cancer therapy: A Metabolism-centric approach9. Metabolic Crossroads: Integrating ROS, SCF and Gut Microbiota in Cancer10. Therapeutic Advances: Modulating Gut Microbiota, ROS, and SCF Pathways in Cancer Treatment11. Precision Medicine in Cancer Metabolism: Personalized Approaches Exploiting Metabolic Vulnerabilities12. Novel Biomarkers and Therapeutic Targets: Harnessing Metabolic Insights for Improved Cancer Management13. Future aspects: Novel Strategies in Cancer Metabolism Research and Clinical Interventions14. Novel approach in Bridging the Gap between Cancer Biology and Metabolism15. Implementing Gut Microbiota, ROS, and SCF Modulation in Cancer Care: Research into Practice